Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	17.99	16.40	13.90
Graham Fair Price	148.07	15728.17	6340.10
PEG	-96.98	< 0.005	-0.15
Price/Book	-3.97	0.18	0.19
Price/Cash Flow	98.22	-4.08	2.06
Prices/Earnings	-83.64	2.11	12.89
Price/Sales	-2.32	0.28	0.29
Price/FCF	98.22	-4.08	2.06
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-17.33	0.25	0.30
Operating Margin	-26.76	0.07	0.09
ROA	487.93	< 0.005	< 0.005
ROE	< 0.005	0.02	487.08
ROIC	< 0.005	0.01	117.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.04	-88.83
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.11	-0.26	-146.06
EPS QOQ	-0.85	4.62	441.51
FCF QOQ	0.16	-1.50	815.63
Revenue QOQ	-0.02	< 0.005	-72.78
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	114.67	106.52	-7.10
Days Sales Outstanding (DSO)	62.75	71.31	13.63
Inventory Turnover	0.78	0.84	7.65
Debt/Capitalization	0.61	0.61	-0.76
Quick Ratio	0.65	0.66	1.69
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22054.68	22580.59	2.38
Cash	7817.09	6994.37	-10.52
Capex	-1903.96	-1337.61	29.75
Free Cash Flow	2029.74	-1006.80	-50.40
Revenue	14331.65	14425.72	0.66
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.20	1.22	1.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.17	14.46	18.82
Naive Interpretation	Member

06 - Financial Health · Weak

Rating